Weed (BUDZ) Cash from Operations (2010 - 2026)
Weed's (BUDZ) quarterly Cash from Operations came in at 57737.0 in Q1 2026, up 19.63% year-on-year from 48263.43 in Q1 2025, and up 51.75% quarter-over-quarter from 119665.0 in Q4 2025.
Weed (BUDZ) Cash from Operations (2010 - 2026) Analysis & Trends
Weed's Cash from Operations history runs 13 years deep, the most recent figure standing at 57737.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 19.63% year-over-year to 57737.0 in Q1 2026; TTM through Mar 2026 was 181035.0, a 41.53% increase from a year earlier, with the FY2025 full-year figure at 195136.0, up 53.04% from the prior year.
- Cash from Operations improved to 57737.0 in Q1 2026 per BUDZ's latest filing, from 119665.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1319.0 in Q2 2025 and bottomed at 451204.0 in Q3 2023.
- The 5-year median for Cash from Operations is 127445.0 (2024), against an average of 150321.12.
- Across the five-year window, Cash from Operations tumbled 194.13% in 2022 and surged 101.61% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 180268.0 in 2022, then tumbled by 88.54% to 339885.0 in 2023, then jumped by 62.5% to 127445.0 in 2024, then rose by 6.1% to 119665.0 in 2025, then surged by 51.75% to 57737.0 in 2026.
- Per Business Quant, the three latest BUDZ Cash from Operations figures stand at 57737.0 (Q1 2026), 119665.0 (Q4 2025), and 4952.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | -57,737.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57,737.00 |
| Mar 31, 2026 | -57,737.00 |
| Dec 31, 2025 | -119,665.00 |
| Dec 31, 2025 | -119,665.00 |
| Sep 30, 2025 | -4,952.00 |
| Sep 30, 2025 | -4,952.00 |
| Jun 30, 2025 | 1,319.00 |
| Jun 30, 2025 | 1,319.00 |
| Mar 31, 2025 | -71,838.00 |
| Mar 31, 2025 | -71,838.00 |
| Dec 31, 2024 | -127,445.00 |
| Dec 31, 2024 | -127,445.00 |
| Sep 30, 2024 | -28,628.00 |
| Sep 30, 2024 | -28,628.00 |
| Jun 30, 2024 | -81,721.00 |
| Jun 30, 2024 | -81,721.00 |
| Mar 31, 2024 | -177,730.00 |
| Mar 31, 2024 | -177,730.00 |
| Dec 31, 2023 | -339,885.00 |
| Dec 31, 2023 | -339,885.00 |